DE69331190T2 - Überbrückte azabicyclische derivate als substanz p antagonisten - Google Patents
Überbrückte azabicyclische derivate als substanz p antagonistenInfo
- Publication number
- DE69331190T2 DE69331190T2 DE69331190T DE69331190T DE69331190T2 DE 69331190 T2 DE69331190 T2 DE 69331190T2 DE 69331190 T DE69331190 T DE 69331190T DE 69331190 T DE69331190 T DE 69331190T DE 69331190 T2 DE69331190 T2 DE 69331190T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- antagonists
- substance
- date nov
- bridged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88511092A | 1992-05-18 | 1992-05-18 | |
PCT/US1993/001429 WO1993023380A1 (en) | 1992-05-18 | 1993-02-23 | Bridged aza-bicyclic derivatives as substance p antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69331190D1 DE69331190D1 (de) | 2002-01-03 |
DE69331190T2 true DE69331190T2 (de) | 2002-04-18 |
Family
ID=25386157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69331190T Expired - Fee Related DE69331190T2 (de) | 1992-05-18 | 1993-02-23 | Überbrückte azabicyclische derivate als substanz p antagonisten |
Country Status (11)
Country | Link |
---|---|
US (1) | US5498614A (de) |
EP (1) | EP0641328B1 (de) |
JP (1) | JP2757234B2 (de) |
AT (1) | ATE209186T1 (de) |
CA (1) | CA2134964C (de) |
DE (1) | DE69331190T2 (de) |
DK (1) | DK0641328T3 (de) |
ES (1) | ES2164657T3 (de) |
FI (2) | FI932229A (de) |
PT (1) | PT641328E (de) |
WO (1) | WO1993023380A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2700472B1 (fr) | 1993-01-19 | 1995-02-17 | Rhone Poulenc Rorer Sa | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2. |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
EP0653208A3 (de) * | 1993-11-17 | 1995-10-11 | Pfizer | Substanz P Antagonisten zur Behandlung oder Verhütung des sonnenbrandes. |
EP0659409A3 (de) * | 1993-11-23 | 1995-08-09 | Pfizer | Substanz P Antagonisten zur Hemmung der Angiogenese. |
EP0655246A1 (de) * | 1993-11-30 | 1995-05-31 | Pfizer Inc. | Substanz P Antagonisten zur Behandlung von durch Helicobacter Pylori oder andere spirale Urease-positive Gram-negative Bakterien verursachten Krankheiten |
US5688960A (en) * | 1995-05-02 | 1997-11-18 | Schering Corporation | Substituted oximes, hydrazones and olefins useful as neurokinin antagonists |
US5696267A (en) * | 1995-05-02 | 1997-12-09 | Schering Corporation | Substituted oximes, hydrazones and olefins as neurokinin antagonists |
EP1021443A4 (de) * | 1995-11-13 | 2001-02-07 | Smithkline Beecham Corp | Hamoregulationische verbindungen |
US5789422A (en) * | 1996-10-28 | 1998-08-04 | Schering Corporation | Substituted arylalkylamines as neurokinin antagonists |
US7101547B1 (en) | 1999-01-22 | 2006-09-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies |
WO2000048999A1 (fr) * | 1999-02-18 | 2000-08-24 | Hisamitsu Pharmaceutical Co., Inc. | Derives de morphane ou sels de ceux-ci et compositions medicinales les contenant |
ZA200701232B (en) | 2004-07-15 | 2008-08-27 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
ES2382814T3 (es) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer |
EP1904069B1 (de) | 2005-07-15 | 2018-06-13 | Albany Molecular Research, Inc. | Aryl- und heteroarylsubstituierte tetrahydrobenzazepine und verwendung damit zur wiederaufnahmeblockierung von norepinephrin, dopamin und serotonin |
US8293900B2 (en) | 2005-09-29 | 2012-10-23 | Merck Sharp & Dohme Corp | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CA2664113C (en) | 2006-09-22 | 2013-05-28 | Merck & Co., Inc. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
BRPI0806245B1 (pt) | 2007-01-10 | 2022-01-25 | Msd Italia S.R.L. | Compostos de fórmula i e seus usos |
CA2682727C (en) | 2007-04-02 | 2016-03-22 | Banyu Pharmaceutical Co., Ltd. | Indoledione derivative |
EP2170076B1 (de) | 2007-06-27 | 2016-05-18 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino-derivate als histondeacetylase-hemmer |
US8598184B2 (en) | 2008-03-03 | 2013-12-03 | Tiger Pharmatech | Protein kinase inhibitors |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
CN102638982B (zh) | 2009-05-12 | 2015-07-08 | 百时美施贵宝公司 | (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途 |
KR20120034644A (ko) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | 아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도 |
CA2760837C (en) | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
WO2011046771A1 (en) | 2009-10-14 | 2011-04-21 | Schering Corporation | SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF |
WO2011163330A1 (en) | 2010-06-24 | 2011-12-29 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
CA2805265A1 (en) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina) |
WO2012024170A2 (en) | 2010-08-17 | 2012-02-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
EP2615916B1 (de) | 2010-09-16 | 2017-01-04 | Merck Sharp & Dohme Corp. | Kondensierte pyrazolderivate als neue erk-hemmer |
WO2012058210A1 (en) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA) |
WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
JP2014514321A (ja) | 2011-04-21 | 2014-06-19 | メルク・シャープ・アンド・ドーム・コーポレーション | インスリン様増殖因子1受容体阻害剤 |
US9023865B2 (en) | 2011-10-27 | 2015-05-05 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
WO2014052563A2 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
MX363243B (es) | 2012-11-28 | 2019-03-14 | Merck Sharp & Dohme | Composiciones para tratar cáncer y usos de dichas composiciones. |
RU2690663C2 (ru) | 2012-12-20 | 2019-06-05 | Мерк Шарп И Доум Корп. | Замещенные имидазопиридины в качестве ингибиторов hdm2 |
US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
EP3833668A4 (de) | 2018-08-07 | 2022-05-11 | Merck Sharp & Dohme Corp. | Prmt5-inhibitoren |
WO2020033284A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3560510A (en) * | 1969-03-05 | 1971-02-02 | Aldrich Chem Co Inc | 2-benzhydrylquinuclidines |
CA1160229A (en) * | 1979-03-13 | 1984-01-10 | Pieter T. Haken | Pyridyliminomethylbenzene derivatives |
CA1231710A (en) * | 1979-07-19 | 1988-01-19 | Haken Pieter Ten | Heterocyclic compounds having fungicidal, herbicidal and plant-growth regulating properties |
EP0100158A3 (de) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | (3-Pyridinyl)-heteroalkarylalkanole, ihre Alkansäuren und ihre Ester |
US4552960A (en) * | 1983-06-20 | 1985-11-12 | Eli Lilly And Company | Fungicidal amines |
US4680283A (en) * | 1984-09-26 | 1987-07-14 | Merck & Co., Inc. | Analogs of substance P and eledoisin |
MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
UA41251C2 (uk) * | 1990-01-04 | 2001-09-17 | Пфайзер, Інк. | Гідровані азотвмісні гетероциклічні сполуки, похідні піперидину, фармацевтична композиція та спосіб пригнічення активності речовини р в організмі |
ATE113947T1 (de) * | 1990-06-01 | 1994-11-15 | Pfizer | 3-amino-2-arylchinuclidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. |
EP0540526B1 (de) * | 1990-07-23 | 1994-12-28 | Pfizer Inc. | Chinuclidinderivate |
EP0550635B1 (de) * | 1990-09-28 | 1995-04-19 | Pfizer Inc. | Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen |
US5138060A (en) * | 1991-01-03 | 1992-08-11 | Pfizer Inc. | Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
HUT65612A (en) * | 1991-01-10 | 1994-07-28 | Pfizer | Process n-alcyl-quinuclidinium salts of p-antagonistic activity |
ES2065175T3 (es) * | 1991-03-01 | 1995-02-01 | Pfizer | Derivados de 1-azabiciclo(3.2.2)nonan-3-amina. |
BR9205807A (pt) * | 1991-03-26 | 1994-06-28 | Pfizer | Preparação estéreo-seletiva de piperidinas substituidas |
KR0154882B1 (ko) * | 1991-06-20 | 1998-11-16 | 알렌 제이. 스피겔 | 질소 함유 헤테로사이클릭 화합물의 플루오로알콕시벤질아미노 유도체 |
TW202432B (de) * | 1991-06-21 | 1993-03-21 | Pfizer |
-
1993
- 1993-02-23 CA CA002134964A patent/CA2134964C/en not_active Expired - Fee Related
- 1993-02-23 US US08/335,726 patent/US5498614A/en not_active Expired - Fee Related
- 1993-02-23 EP EP93906038A patent/EP0641328B1/de not_active Expired - Lifetime
- 1993-02-23 WO PCT/US1993/001429 patent/WO1993023380A1/en active IP Right Grant
- 1993-02-23 PT PT93906038T patent/PT641328E/pt unknown
- 1993-02-23 ES ES93906038T patent/ES2164657T3/es not_active Expired - Lifetime
- 1993-02-23 DK DK93906038T patent/DK0641328T3/da active
- 1993-02-23 DE DE69331190T patent/DE69331190T2/de not_active Expired - Fee Related
- 1993-02-23 AT AT93906038T patent/ATE209186T1/de not_active IP Right Cessation
- 1993-02-23 JP JP5520178A patent/JP2757234B2/ja not_active Expired - Fee Related
- 1993-05-17 FI FI932229A patent/FI932229A/fi unknown
-
2000
- 2000-01-17 FI FI20000085A patent/FI106457B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT641328E (pt) | 2002-04-29 |
CA2134964A1 (en) | 1993-11-25 |
FI20000085A (fi) | 2000-01-17 |
FI106457B (fi) | 2001-02-15 |
JPH07503483A (ja) | 1995-04-13 |
DK0641328T3 (da) | 2002-05-21 |
US5498614A (en) | 1996-03-12 |
ES2164657T3 (es) | 2002-03-01 |
JP2757234B2 (ja) | 1998-05-25 |
WO1993023380A1 (en) | 1993-11-25 |
EP0641328B1 (de) | 2001-11-21 |
DE69331190D1 (de) | 2002-01-03 |
FI932229A (fi) | 1993-11-19 |
EP0641328A1 (de) | 1995-03-08 |
FI932229A0 (fi) | 1993-05-17 |
CA2134964C (en) | 1997-12-30 |
ATE209186T1 (de) | 2001-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69331190D1 (de) | Überbrückte azabicyclische derivate als substanz p antagonisten | |
MX9203053A (es) | Derivados de aza nor bornano. | |
ATE166650T1 (de) | Spiroazacyclischderivate als substanz p antagonisten | |
DE69223989D1 (en) | Azyklische ethylendiaminderivate als 'substance p rezeptor' antagonisten | |
DK0607164T3 (da) | Kondenserede tricykliske nitrogenholdige heterocykliske forbindelser som substans P-receptorantagonister | |
MX9203018A (es) | Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |